• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有姜烯酮的脂质体的新型配方,用壳聚糖进行包被,并评估其体外潜在的抗癌作用。

Novel formulation of parthenolide-loaded liposome coated with chitosan and evaluation of its potential anticancer effects in vitro.

机构信息

Department of Chemistry, Shahrood Branch, Islamic Azad University, Shahrood, Iran.

Department of Biochemistry, Shahrood Branch, Islamic Azad University, Shahrood, Iran.

出版信息

Mol Biol Rep. 2024 Feb 27;51(1):369. doi: 10.1007/s11033-024-09325-8.

DOI:10.1007/s11033-024-09325-8
PMID:38411765
Abstract

BACKGROUND

In this study the formulation of parthenolide (PN), an anticancer agent extracted from a natural product, into a liposome (PN-liposome), was examined. The surface of the PN-liposome was modified using chitosan (PN-chitosome). By using real-time quantitative PCR and flow cytometry, we examined the release of PN-chitosomes, cytotoxicity, and ability to induce apoptosis in vitro.

METHODS AND RESULTS

According to the present study, PN-chitosomes had a size of 251 nm which is acceptable for efficient enhanced permeation and retention (EPR) performance. PN-chitosomes were confirmed to be spherical in shape and size through FESEM analysis. In terms of encapsulation efficiency, 94.5% was achieved. PN-chitosome possessed a zeta potential of 34.72 mV, which was suitable for its stability. According to the FTIR spectra of PN and PN-chitosome, PN was chemically stable due to the intermolecular interaction between the liposome and the drug. After 48 h, only 10% of the PN was released from the PN-chitosome in PBS (pH 7.4), and less than 20% was released after 144 h.

CONCLUSION

In a dose-dependent manner, PN-chitosome exhibited anticancer properties that were more cytotoxic against cancer cells than normal cells. Moreover, the formulation activated both the apoptosis pathway and cytotoxic genes in real-time qPCR experiments. According to the cytotoxicity and activating apoptosis of the prepared modified particle, PN-chitosome may be helpful in the treatment of cancer.

摘要

背景

本研究考察了将天然产物中提取的抗癌剂小白菊内酯(PN)制成脂质体(PN-脂质体)的配方。通过使用壳聚糖(PN-壳聚糖)对 PN-脂质体的表面进行修饰。通过实时定量 PCR 和流式细胞术,我们检测了 PN-壳聚糖的释放、细胞毒性以及体外诱导细胞凋亡的能力。

方法和结果

根据本研究,PN-壳聚糖的粒径为 251nm,这对于有效的增强渗透和保留(EPR)性能是可接受的。FESEM 分析证实 PN-壳聚糖为球形且粒径均匀。包封效率达到 94.5%。PN-壳聚糖的 Zeta 电位为 34.72mV,这有利于其稳定性。根据 PN 和 PN-壳聚糖的傅里叶变换红外(FTIR)光谱,由于脂质体与药物之间的分子间相互作用,PN 化学稳定。在 PBS(pH 7.4)中,48h 后只有 10%的 PN 从 PN-壳聚糖中释放,144h 后释放量不到 20%。

结论

PN-壳聚糖以剂量依赖的方式表现出抗癌特性,对癌细胞的细胞毒性比对正常细胞更强。此外,制剂在实时 qPCR 实验中激活了细胞凋亡途径和细胞毒性基因。根据所制备的改性颗粒的细胞毒性和诱导细胞凋亡的作用,PN-壳聚糖可能有助于癌症的治疗。

相似文献

1
Novel formulation of parthenolide-loaded liposome coated with chitosan and evaluation of its potential anticancer effects in vitro.载有姜烯酮的脂质体的新型配方,用壳聚糖进行包被,并评估其体外潜在的抗癌作用。
Mol Biol Rep. 2024 Feb 27;51(1):369. doi: 10.1007/s11033-024-09325-8.
2
A novel nanoformulation of parthenolide coated with polydopamine shows selective cytotoxicity and induces apoptosis in gastric cancer cells.一种用聚多巴胺包覆的小白菊内酯新型纳米制剂显示出对胃癌细胞的选择性细胞毒性并诱导其凋亡。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):4435-4445. doi: 10.1007/s00210-023-02907-6. Epub 2023 Dec 18.
3
Rosuvastatin Flexible Chitosomes: Development, In Vitro Evaluation and Enhancement of Anticancer Efficacy Against HepG2 and MCF7 Cell Lines.罗苏伐他汀柔性壳聚糖纳米粒的研制及其对 HepG2 和 MCF7 细胞系抗癌活性的体外评价和增强作用。
AAPS PharmSciTech. 2024 Oct 7;25(7):234. doi: 10.1208/s12249-024-02957-w.
4
Preparation and Characterization of Novel Polyelectrolyte Liposomes Using Chitosan Succinate Layered over Chitosomes: A Potential Strategy for Colon Cancer Treatment.使用琥珀酸壳聚糖包覆壳聚糖体的新型聚电解质脂质体的制备与表征:一种结肠癌治疗的潜在策略
Biomedicines. 2024 Jan 8;12(1):126. doi: 10.3390/biomedicines12010126.
5
Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma - A rare thoracic cancer.载有二甲双胍的壳聚糖纳米粒治疗恶性胸膜间皮瘤-一种罕见的胸部癌症。
Int J Biol Macromol. 2020 Oct 1;160:128-141. doi: 10.1016/j.ijbiomac.2020.05.146. Epub 2020 May 20.
6
Chitosomes Loaded with Docetaxel as a Promising Drug Delivery System to Laryngeal Cancer Cells: An In Vitro Cytotoxic Study.载多西紫杉醇壳聚糖纳米粒作为一种有前途的药物传递系统对喉癌细胞的体外细胞毒性研究。
Int J Mol Sci. 2023 Jun 8;24(12):9902. doi: 10.3390/ijms24129902.
7
Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide.用于包封环丙沙星和依托泊苷的壳聚糖包被脂质体制剂
Pharmaceutics. 2024 Aug 2;16(8):1036. doi: 10.3390/pharmaceutics16081036.
8
Chitosan coated liposomes as an innovative nanocarrier for drugs.壳聚糖包被脂质体作为一种创新的药物纳米载体。
J Biomed Nanotechnol. 2012 Apr;8(2):240-50. doi: 10.1166/jbn.2012.1375.
9
TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.TPGS-壳聚糖纳米粒作为一种有效的口服给药系统用于提高辅酶Q10的生物利用度。
Eur J Pharm Biopharm. 2015 Jan;89:339-46. doi: 10.1016/j.ejpb.2014.12.026. Epub 2014 Dec 24.
10
Preparation, characterization and release behavior of chitosan-coated nanoliposomes (chitosomes) containing olive leaf extract optimized by response surface methodology.采用响应面法优化的负载橄榄叶提取物的壳聚糖包被纳米脂质体(壳聚糖纳米粒)的制备、表征及释放行为
J Food Sci Technol. 2021 Sep;58(9):3430-3443. doi: 10.1007/s13197-021-04972-2. Epub 2021 Jan 25.

引用本文的文献

1
Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide.用于包封环丙沙星和依托泊苷的壳聚糖包被脂质体制剂
Pharmaceutics. 2024 Aug 2;16(8):1036. doi: 10.3390/pharmaceutics16081036.

本文引用的文献

1
Chitin and Chitosan: Prospective Biomedical Applications in Drug Delivery, Cancer Treatment, and Wound Healing.几丁质和壳聚糖:药物传递、癌症治疗和伤口愈合方面有前景的生物医学应用。
Mar Drugs. 2022 Jul 17;20(7):460. doi: 10.3390/md20070460.
2
Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties.小白菊内酯及其可溶性类似物:具有抗肿瘤特性的多功能化合物。
Biomedicines. 2022 Feb 21;10(2):514. doi: 10.3390/biomedicines10020514.
3
The current knowledge concerning solid cancer and therapy.关于实体癌与治疗的当前知识。
J Biochem Mol Toxicol. 2021 Nov;35(11):e22900. doi: 10.1002/jbt.22900. Epub 2021 Aug 31.
4
RETRACTED: Investigation of the Potential of Nebivolol Hydrochloride-Loaded Chitosomal Systems for Tissue Regeneration: In Vitro Characterization and In Vivo Assessment.撤回:载盐酸奈必洛尔的壳聚糖体系统用于组织再生的潜力研究:体外表征与体内评估
Pharmaceutics. 2021 May 11;13(5):700. doi: 10.3390/pharmaceutics13050700.
5
Targeting metastatic cancer.针对转移性癌症。
Nat Med. 2021 Jan;27(1):34-44. doi: 10.1038/s41591-020-01195-4. Epub 2021 Jan 13.
6
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide.用靶向肿瘤细胞和肿瘤内皮细胞的双载体制备载多柔比星长循环脂质体提高其抗肿瘤疗效。
J Drug Target. 2021 Jul;29(6):617-630. doi: 10.1080/1061186X.2020.1870230. Epub 2021 Mar 8.
7
Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma - A rare thoracic cancer.载有二甲双胍的壳聚糖纳米粒治疗恶性胸膜间皮瘤-一种罕见的胸部癌症。
Int J Biol Macromol. 2020 Oct 1;160:128-141. doi: 10.1016/j.ijbiomac.2020.05.146. Epub 2020 May 20.
8
Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study.载药量高的姜黄素稳定纳米脂质体制剂的制备及表征:体内外抗肿瘤研究。
Int J Pharm. 2020 Apr 30;580:119211. doi: 10.1016/j.ijpharm.2020.119211. Epub 2020 Mar 7.
9
Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine.壳聚糖包被脂质体的研制及其用于乙酰半胱氨酸的肺部给药。
Int J Biol Macromol. 2020 Aug 1;156:1455-1463. doi: 10.1016/j.ijbiomac.2019.11.190. Epub 2019 Nov 23.
10
Advances in chemistry and bioactivity of parthenolide.紫萍内酯的化学和生物活性研究进展。
Nat Prod Rep. 2020 Apr 1;37(4):541-565. doi: 10.1039/c9np00049f. Epub 2019 Nov 25.